SOURCE: Dyer & Berens LLP

Dyer & Berens LLP

July 13, 2010 12:48 ET

Dyer & Berens LLP Encourages Amedisys, Inc. Investors to Consider Their Legal Options in Pending Class Action Prior to the August 9, 2010 Lead Plaintiff Deadline -- AMED

DENVER, CO--(Marketwire - July 13, 2010) -  Dyer & Berens LLP (www.DyerBerens.com) today encouraged investors who purchased or acquired Amedisys, Inc. (NASDAQ: AMED) securities between February 23, 2010 and May 13, 2010, inclusive to consider whether to seek a "lead plaintiff" appointment in the securities class action pending in the United States District Court for the Middle District of Louisiana. If you wish to serve as a lead plaintiff, you must seek such an appointment no later than August 9, 2010. 

If you wish to discuss the class action lawsuit or have any questions concerning this notice or your rights or interests, please contact Jeffrey A. Berens, Esq., at (888) 300-3362 x302, (303) 861-1764, or via email at jeff@dyerberens.com. Any member of the putative class may move the court to serve as a lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Although investors' ability to share in any recovery is not affected by their decision to seek appointment, lead plaintiffs make important decisions which could affect the overall recovery for class members.

The class action complaint alleges that defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the company's business, operations, and prospects. Specifically, defendants allegedly failed to disclose: (1) that AMED's reported sales and earnings growth were materially impacted by a scheme whereby the company intentionally increased the number of in-home therapy visits to patients for the purpose of triggering higher reimbursement rates under the Medicare home health prospective payment system; (2) that the company's reported sales and earnings were inflated by the scheme and subject to recoupment by Medicare; (3) that the company was in material violation of its Code of Ethical Business Conduct and compliance due to the scheme; and (4) based on the foregoing, defendants lacked a reasonable basis for their positive statements about the company, its prospects and growth.

To review a copy of the complaint, please contact Dyer & Berens LLP via telephone or email, or go to our website at www.DyerBerens.com. Dyer & Berens LLP specializes in complex class action litigation on behalf of injured investors throughout the nation. The firm's extensive experience in securities litigation, particularly in cases brought under the Private Securities Litigation Reform Act, has contributed to the recovery of hundreds of millions of dollars for aggrieved investors. 

Contact Information

  • Contact:

    Jeffrey A. Berens
    Dyer & Berens LLP
    303 East 17th Avenue, Suite 300
    Denver, CO 80203
    Tel: (888) 300-3362 x302
    (303) 861-1764
    Email: Email Contact